MARKET

SVA

SVA

Sinovac Biotech Ltd
NASDAQ
6.47
0.00
0.00%
Suspension 04:00 09/25 EDT
OPEN
--
PREV CLOSE
6.47
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
6.58
52 WEEK LOW
6.25
MARKET CAP
464.94M
P/E (TTM)
-4.7323
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SVA last week (0831-0904)?
Weekly Report · 2d ago
Weekly Report: what happened at SVA last week (0824-0828)?
Weekly Report · 08/31 10:01
Weekly Report: what happened at SVA last week (0817-0821)?
Weekly Report · 08/24 10:02
Sinovac Posts Wider H1 2026 Loss as Overseas Vaccine Sales and New Approvals Reshape Growth Mix
TipRanks · 08/17 12:31
Sinovac Biotech H1 EPS $(0.84) Down From $0.06 YoY, Sales $147.079M Up From $130.270M YoY
Benzinga · 08/17 12:18
Sinovac Biotech reports 1H EPS (84c) vs. (30c) last year
TipRanks · 08/17 12:05
Weekly Report: what happened at SVA last week (0810-0814)?
Weekly Report · 08/17 10:02
Weekly Report: what happened at SVA last week (0803-0807)?
Weekly Report · 08/10 09:59
More
About SVA
Sinovac Biotech Ltd (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, hand foot and mouth disease (HFMD), seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine.

Webull offers Sinovac Biotech Ltd stock information, including NASDAQ: SVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SVA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SVA stock methods without spending real money on the virtual paper trading platform.